|
⚲
|
| Keyboard |
| KKR Genetic Disorder GP LLC
✚
|
|
|---|---|
| CIK # | 0001780428 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001780428] | |
| 4 | [0001780428] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
BridgeBio Pharma LLC BBIO
Common Stock
|
2025-05-12 | Sell | 6,000,000 | $34.20 | 205,200,000 |
|
BridgeBio Pharma LLC BBIO
Common Stock
|
2025-03-05 | Sell | 6,000,000 | $32.96 | 197,760,000 |
|
BridgeBio Pharma LLC BBIO
Common Stock
|
2024-09-13 | Sell | 5,800,000 | $25.75 | 149,350,000 |
|
BridgeBio Pharma LLC BBIO
Common Stock
|
2021-02-17 | Sell | 3,450,000 | $60.47 | 208,621,500 |
|
BridgeBio Pharma LLC BBIO
Common Stock
|
2020-05-28 | Sell | 2,389,690 | $33.39 | 79,791,749 |
|
BridgeBio Pharma LLC BBIO
Common Stock
|
2019-07-01 | Buy | 2,647,100 | $17.00 | 45,000,700 |
|
BridgeBio Pharma LLC BBIO
Series D Preferred Units · derivative
|
2019-07-01 | Conversion | 50,446,451 | ||
|
BridgeBio Pharma LLC BBIO
Series B Preferred Units · derivative
|
2019-07-01 | Conversion | 81,022,727 | ||
|
BridgeBio Pharma LLC BBIO
Series C Preferred Units · derivative
|
2019-07-01 | Conversion | 36,246,893 | ||
|
BridgeBio Pharma LLC BBIO
Common Stock
|
2019-07-01 | Conversion | 34,253,561 |